To assess the effect of CD24 deficiency on mammary tumor development and growth, MMTV-PyMT and Apc1572T/+ mice that were either CD24+/+ or CD24-/- were palpated weekly to establish the time at which mammary tumors could first be detected after tumor initiation. This evidence concerns the gene CD24 and breast cancer.